Increased investment and cross-sector collaboration are needed to ensure the widespread adoption, delivery, and implementation of new health technologies

PDPs, national health systems, multilateral organizations, donors, and advocates have learned that achieving health impact requires an end-to-end approach. This includes investing to ensure products are affordable, rapidly available, and widely and equitably accessible by addressing challenges relating to manufacturing, market competition, affordability, forecasting, and training of health service providers. Accelerating and expanding access to new products requires dedicated investment and creative and multi-sectored partnerships. With more products approaching and reaching the market than ever before, the need to invest in access is increasingly critical and urgent.